Showing posts with label Vanguard. Show all posts
Showing posts with label Vanguard. Show all posts
Friday, June 27, 2025

When the tech "hits the fan" so to speak, who might bid for Cabaletta Bio and their cutting edge technology?

›
  Cabaletta Bio is a compelling acquisition target  in a growing niche— cell therapy for autoimmune diseases . Its unique platform, strong e...
Tuesday, May 27, 2025

Cabaletta Bio (CABA) is a microcap stock with a serious pipeline in the Healthcare field, and a possible takeover target. Read on...

›
  Cabaletta Bio Might See a Takeover Offer in the Near Future Date: May 27, 2025 Ticker: NASDAQ: CABA Sector: Biotechnology Market Ca...
Friday, March 7, 2025

What's up with UiPath, it's Robotics Automation and it's recent push into healthcare?

›
  Below is a comprehensive investment and business report on UiPath  N Y S E : P A T H   Please note that all figures and information are b...
Thursday, July 25, 2024

Here's why institutional investors are investing in AEVA Technologies at this time and who currently owns the stock!

›
Institutional investors are showing interest in Aeva Technologies (AEVA) for several reasons: Innovative Technology : Aeva is known for its ...
Monday, July 8, 2024

The business partnerships that IONQ has in advancing trapped ion, quantum computing, are a who's who of business and Government and so is their list of investors

›
  IonQ has been making significant strides in the field of quantum computing, positioning itself at the forefront of this cutting-edge techn...
Sunday, July 7, 2024

Editas Medicine $EDIT has pioneered the use of CRISPR technology to develop innovative genomic medicines, potentially transforming the treatment of a wide range of genetic diseases

›
  Editas Medicine is a viable player in the biotech field due to several factors: Technological Advancements : Editas focuses on CRISPR-Ca...